We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ImmBio Initiates First-in-Human Studies of PnuBioVax

News   Dec 11, 2015

 
ImmBio Initiates First-in-Human Studies of PnuBioVax
 
 
 

RELATED ARTICLES

Drug Improves Outcomes & Survival Rates in Patients with Bone Marrow Cancer

News

In the largest study of its kind, researchers at Newcastle University have led national research into the treatment of patients with newly diagnosed myeloma. The results, published by The Lancet Oncology, show an improvement for those who received ongoing therapy with a drug called lenalidomide, compared to those not receiving it.

READ MORE

Shortcut to Recreating Key HIV Antibody for Vaccines

News

A portion of the roadmap toward effective neutralization of HIV has been clarified, identifying the steps that a critical HIV antibody takes to develop and maintain its ability to neutralize the virus.

READ MORE

Statins Have Low Risk of Side Effects

News

The cholesterol-lowering drugs called statins have demonstrated substantial benefits in reducing the risk of heart attacks and strokes caused by blood clots (ischemic strokes) in at-risk patients. Since statins are associated with a low risk of side effects, the benefits of taking them outweigh the risks, according to a scientific statement from the American Heart Association that reviewed multiple studies evaluating the safety and potential side effects of these drugs.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE